Drug makers release safety pledge to 'ensure public confidence' in COVID-19 vaccine process
Companies behind a number of COVID-19 vaccine candidates have released a joint pledge in an effort to "ensure public confidence" in the process.
Johnson & Johnson, Moderna, and Novavax were among the nine drug companies working on potential COVID-19 vaccines whose CEOs signed a joint pledge released on Tuesday, saying that they won't submit for approval until "after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA," also promising to "always make the safety and well-being of vaccinated individuals our top priority," per The Washington Post.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Centers for Disease Control and Prevention recently told states to prepare to potentially begin distributing a COVID-19 vaccine as soon as November, leading to "heightened concerns that the Trump administration is seeking to rush the distribution of a vaccine," The New York Times wrote. The White House said "any approval will maintain the FDA's gold standard for safety and testing."
The drug companies say they're looking to "help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved." Previously, The Wall Street Journal reported that this "unusual joint move" would be made, and the Post described the statement as an "extraordinary effort to bolster public faith in a vaccine."
